HTR6 and Alzheimer disease: Animal experiments have revealed an additional mechanism: SB271046, a 5-HT6R antagonist (10 mg/kg, i.p.), reduced Aβ1-42 levels in the brains of AD mice and improved learning and memory deficits by inhibiting γ-secretase activity via APBA1/2 modulation [32].